Clinical Trial Update: XKH001 Injection in Healthy Subjects [Phase 1, Phase 2]

View source ↗

Summary

Beijing Kanova Biopharmaceutical Co., LTD's XKH001 underwent Phase 1 and Phase 2 trials for asthma, and the studies have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• XKH001

Snippet

Sponsor: Beijing Kanova Biopharmaceutical Co., LTD | Conditions: Asthma | Phase 1, Phase 2 | Status: COMPLETED